Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

Home > Science Hub > Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
Back to the list

November 16, 2023

You might also be interested by

CellTalk Blog

Next-Gen Immune Monitoring: The Value of Single-Cell Sequencing

August 12, 2025

More info

Web News

Let's Talk: A Conversation with Dr. Charles Sawyers

July 21, 2025

More info

Web News

CellCarta and Tivenix Strategic Partnership

July 21, 2025

More info

Web News

CellCarta Appoints Elliott Miller as Chief Financial Officer

July 7, 2025

More info